Bone remodeling is a complex process of coordinated resorption and formatio
n of bone, which is regulated by systemic hormones and by local factors. We
have previously shown that the peptide hormone adrenomedullin is mitogenic
to osteoblastic cells in vitro and that it promotes bone growth in vivo. T
he aim of the present study was to characterize the expression of molecules
that may mediate adrenomedullin signaling in osteoblasts and to investigat
e the expression of adrenomedullin itself in these cells. The first adrenom
edullin receptor that was cloned is the seven-transmembrane G protein-coupl
ed receptor, L1. Two additional receptors for adrenomedullin, which arise f
rom interactions between calcitonin receptor-like receptor and receptor act
ivity modifying proteins 2 or 3, have now been described. In the current st
udy, we used RT-PCR and Northern blot analysis to demonstrate that messenge
r RNA for the three adrenomedullin receptors, as well as for adrenomedullin
itself, is expressed in primary rat osteoblasts. Treating primary osteobla
sts with transforming growth factor-p and insulin-like growth factor-beta m
oderately reduced adrenomedullin RNA levels, whereas PTH had no effect. We
have shown by immunocytochemistry that adrenomedullin peptide is present in
osteoblasts, and by competitive binding assays that I-125-adrenomedullin b
inds with high affinity to intact osteoblasts and to osteoblast cell membra
nes. Coexpression of adrenomedullin and adrenomedullin receptors in osteobl
asts, taken together with our previous finding that adrenomedullin is mitog
enic to these cells, raises the possibility that this peptide is a local re
gulator of bone growth.